강창경 (서울대학교 의과대학)님 | 한빛사연구자 > 한빛사

서울대학교 의과대학

CV File

응용의학

최종업데이트 2022.05.18.

Cytomegalovirus reactivation in the lower respiratory tract as an independent risk factor for mortality in critically Ill patients
- Crit. Care, May 02 2025, 29 (1) 177 | https://doi.org/10.1186/s13054-025-05324-8
- 2025-05
- 의약학
- 한빛사논문
Tracking antigen-specific TCR clonotypes in SARS-CoV-2 infection reveals distinct severity trajectories
- J. Med. Virol., Nov 2023, 95 (11) | https://doi.org/10.1002/jmv.29199
- 2023-11
- 의약학
- 한빛사논문
Empirical versus preemptive broad-spectrum antifungal therapy for acute myelogenous leukemia in the era of antimold prophylaxis
- Int. J. Antimicrob. Agents, 2023 Aug 16;106954 | https://doi.org/10.1016/j.ijantimicag.2023.106954
- 2023-08
- 의약학
- 한빛사논문
Comparable humoral and cellular immunity against Omicron variant BA.4/5 of once-boosted BA.1/2 convalescents and twice-boosted COVID-19-naïve individuals
- J. Med. Virol., First published: 08 February 2023 | https://doi.org/10.1002/jmv.28558
- 2023-02
- 의약학
- 한빛사논문
Clinical impact of clonal hematopoiesis on severe COVID-19 patients without canonical risk factors
- Haematologica, Sep 15, 2022 | https://doi.org/10.3324/haematol.2022.280621
- 2022-09
- 생명과학
- 한빛사논문
Single-cell transcriptome analyses reveal distinct gene expression signatures of severe COVID-19 in the presence of clonal hematopoiesis
- Exp. Mol. Med., 2022 Oct;54(10):1756-1765 | https://doi.org/10.1038/s12276-022-00866-1
- 2022-10
- 생명과학
- 한빛사논문
Broad humoral and cellular immunity elicited by one-dose mRNA vaccination 18 months after SARS-CoV-2 infection
- BMC Med., Published 04 May 2022 | https://doi.org/10.1186/s12916-022-02383-4
- 2022-05
- 생명과학
- 한빛사논문
Why are children less affected than adults by severe acute respiratory syndrome coronavirus 2 infection?
- Cell. Mol. Immunol., Published 24 March 2022 | https://doi.org/10.1038/s41423-022-00857-2
- 2022-03
- 의약학
- 한빛사논문

연구자 ID

저자논문

저자논문

저자논문

저자논문

CV 열람하기

연락처 보기